US2019201069A1PendingUtilityA1

Methods and devices to treat nasal airways

Assignee: AERIN MEDICAL INCPriority: Jun 14, 2011Filed: Mar 8, 2019Published: Jul 4, 2019
Est. expiryJun 14, 2031(~4.9 yrs left)· nominal 20-yr term from priority
A61B 18/20A61B 2018/00702A61B 18/1477A61B 2018/0262A61B 18/1485A61B 2018/00875A61B 2018/00023A61B 2018/00577A61B 2017/32007A61B 2018/1861A61B 18/1206A61B 2018/143A61B 2018/1253A61B 2017/248A61B 2018/00791A61B 2018/00005A61B 2018/0091A61B 2018/00595A61B 2018/00327A61B 2018/126F04C 2270/041A61B 2018/0225A61B 18/1815A61F 5/56A61B 18/1442A61B 2018/00982A61B 2018/00821A61B 2018/0212A61N 5/025A61B 2017/320069A61N 5/0603A61B 2018/1807A61B 2018/00922A61N 5/0625A61B 18/16A61B 2018/00708A61B 2018/0016A61B 18/14A61B 2018/00642A61B 2018/00178A61F 5/08A61B 2018/00886A61B 2018/0022A61B 17/320068A61B 2018/1425A61B 18/02A61B 2018/00994A61B 17/2816A61F 7/10A61B 18/06A61N 7/022A61N 1/403A61B 18/1445A61B 18/085A61B 5/01A61N 1/40A61B 18/12A61B 18/18
72
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods and devices for treating nasal airways are provided. Such devices and methods may improve airflow through an internal and/or external nasal valve, and comprise the use of mechanical re-shaping, energy application and other treatments to modify the shape, structure, and/or air flow characteristics of an internal nasal valve, an external nasal valve or other nasal airways.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for reshaping a nasal airway in a patient, the method comprising:
 positioning an inflatable balloon of a reshaping device in an uninflated configuration between a nasal septum and a lateral wall of the nasal airway;   inflating the inflatable balloon to an inflated configuration to cause the inflatable balloon to press against the lateral wall;   maintaining the inflatable balloon in the inflated configuration within the nasal airway for a period of time; and   removing the inflatable balloon from the nasal airway, wherein a diameter of the nasal airway remains expanded after removal of the reshaping device and healing of the lateral wall.   
     
     
         2 . The method of  claim 1 , wherein the inflatable balloon is positioned between an upper portion of the nasal septum and the lateral wall, wherein the inflatable balloon is inflated until a nasal valve angle of the nasal airway reaches a desired size, and wherein the diameter of the nasal airway comprises a diameter at or near a nasal valve of the nasal airway. 
     
     
         3 . The method of  claim 2 , wherein the expanded diameter of the nasal airway causes a decrease in airflow resistance or a decrease in perceived airflow resistance in the nasal airway. 
     
     
         4 . The method of  claim 1 , further comprising applying energy to the lateral wall with the inflatable balloon to fix the lateral wall in a desired conformational shape before, during or after inflating the balloon. 
     
     
         5 . The method of  claim 4 , wherein the energy is applied via an energy delivery member coupled with an outer surface of the inflatable balloon. 
     
     
         6 . The method of  claim 4 , wherein applying the energy comprises inflating the inflatable balloon with heated inflation fluid. 
     
     
         7 . A method of treating a patient's nasal airway, the method comprising:
 positioning a treatment element within the nasal airway adjacent to a nasal tissue to be treated; and   expanding the treatment element to apply sufficient force to the nasal tissue to alter a shape of the nasal tissue,   wherein the nasal tissue at least partially maintains the altered shape after the treating element is removed and the nasal tissue heals.   
     
     
         8 . The method of  claim 7 , wherein the method is performed without creating a surgical incision or implanting a surgical implant. 
     
     
         9 . The method of  claim 7 , wherein expanding the treatment element comprises inflating a balloon. 
     
     
         10 . The method of  claim 7 , further comprising maintaining the treatment element in an expanded configuration within the nasal airway for a period of time. 
     
     
         11 . The method of  claim 7 , further comprising applying energy to the nasal tissue with the treatment element. 
     
     
         12 . The method of  claim 11 , wherein applying energy comprises applying energy in a form selected from the group consisting of ultrasound, microwave, heat, radiofrequency, electrical, light and laser. 
     
     
         13 . The method of  claim 11 , wherein applying energy comprises injuring the nasal tissue. 
     
     
         14 . The method of  claim 11 , further comprising, before applying energy, injecting a polymerizing liquid into or below the nasal tissue. 
     
     
         15 . The method of  claim 11 , wherein expanding the treatment element and applying the energy modifies a mechanical property of the nasal tissue in a manner that increases a volumetric airflow rate of air flowing from an exterior of the patient's body into the patient's nasopharynx without changing a shape of an internal nasal valve. 
     
     
         16 . The method of  claim 7 , wherein the nasal tissue comprises at least one of tissue at a nasal valve or tissue adjacent a nasal valve, and wherein altering the shape of the tissue comprises expanding a diameter of the nasal airway at or near the nasal valve. 
     
     
         17 . The method of  claim 7 , further comprising delivering a cauterizing agent to the nasal tissue. 
     
     
         1 - 17 . (canceled) 
     
     
         18 . A device for treating a nasal airway in a patient, the device comprising:
 a handle;   a shaft extending from the handle and including an inflation lumen;   an inflatable cryotherapy balloon attached to a distal end of the shaft and sized to be inserted into a nostril, wherein an interior of the cryotherapy balloon is in fluid communication with the inflation lumen; and   a source of low-temperature liquid attachable to the handle so as to circulate the low-temperature liquid through the inflation lumen and the interior of the cryotherapy balloon to inflate the cryotherapy balloon and treat at least one target tissue in the nasal airway.   
     
     
         19 . The device of  claim 18 , wherein the low-temperature liquid comprises liquid nitrogen. 
     
     
         20 . The device of  claim 18 , wherein an expanded diameter of the cryotherapy balloon is sized to reshape the at least one target tissue when the cryotherapy balloon is expanded. 
     
     
         21 . The device of  claim 18 , wherein the cryotherapy balloon is configured to remove energy from the at least one target tissue over an entire outer surface of the cryotherapy balloon. 
     
     
         22 . The device of  claim 18 , wherein the cryotherapy balloon is configured to deliver cryotherapy to a selected tissue depth, and wherein the at least one target tissue is located at the selected tissue depth.

Join the waitlist — get patent alerts

Track US2019201069A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.